The key to successful treatment of AIH is to treat aggressively & long enough. Congrats to this team who gathered data on a large # of patients with AIH treated w/ budesonide vs. prednisone. It reinforces the belief that treating w/ budesonide has a limited role in treating AIH.
Díaz-González Á et al. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
#LiverTwitter
https://t.co/PUmbzGEKrE
The American Journal of Gastroenterology has published this updated, practical guide for clinicians' management of PBC. Our Director, Dr. Pratt, was proud to be part of the writing group.
https://t.co/TtexAJRYv4
Congrats to the investigators of this open label extension study further suggesting a potential role for non-steroidal FXR agonist in #PSC.
https://t.co/FaBvjdV8T7
Our director, Dr. Dan Pratt, will be moderating a webinar tonight hosted by @PSCPartners. Dr. Josh Korzenik and Dr. Jennifer Lai will be discussing PSC, IBD, and nutrition. See below for more information and registration details.
Dinner with the MGH Hepatology Team. Congratulations to the amazing Dr. Jenny Wang – the latest graduate of the MGH Advanced Liver Fellowship. Good Luck in Chicago!
Thank you for following the MGH Autoimmune and Cholestatic Liver Center. We are dedicated to unraveling the cause, identifying new treatments, and providing care for patients with immune mediated liver diseases.